Home › Funds › Renaissance Technologies › CHE
Renaissance Technologies position in CHE
CHEMED CORP NEW · Health Care
Latest position (Q2 2026)39.08K sh
Reported value held$18.20M
Portfolio Weight0.03%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 144.50K | $67.21M | New |
| Q4 2021 | 130.10K | $68.83M | Reduce |
| Q1 2022 | 128.50K | $65.09M | Reduce |
| Q2 2022 | 166.00K | $77.92M | Add |
| Q3 2022 | 133.30K | $58.19M | Reduce |
| Q4 2022 | 118.10K | $60.28K | Reduce |
| Q1 2023 | 104.10K | $55.98K | Reduce |
| Q2 2023 | 97.30K | $52.70K | Reduce |
| Q3 2023 | 77.80K | $40.43K | Reduce |
| Q4 2023 | 89.40K | $52.28K | Add |
| Q1 2024 | 73.93K | $47.45K | Reduce |
| Q2 2024 | 61.80K | $33.53M | Reduce |
| Q3 2024 | 47.75K | $28.70M | Reduce |
| Q4 2024 | 47.10K | $24.95M | Reduce |
| Q1 2025 | 51.10K | $31.44M | Add |
| Q1 2025 | 51.10K | $31.44M | Add |
| Q2 2025 | 88.50K | $43.09M | Add |
| Q2 2025 | 88.50K | $43.09M | Add |
| Q3 2025 | 49.00K | $21.94M | Reduce |
| Q4 2025 | 12.54K | $5.37M | Reduce |
| Q1 2026 | 12.34K | $4.66M | Reduce |
| Q2 2026 | 39.08K | $18.20M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CHE
- BlackRock Inc 1.48M sh · $691.29M · Q2 2026
- Vanguard Group 1.47M sh · $629.92M · Q4 2025
- AQR Capital Management 972.47K sh · $446.21M · Q2 2026
- Geode Capital Management 413.94K sh · $192.82M · Q2 2026
- JPMorgan Chase & Co 403.39K sh · $185.81M · Q2 2026
- Morgan Stanley 232.30K sh · $108.19M · Q2 2026
- Northern Trust Corp 199.15K sh · $92.75M · Q2 2026
- Goldman Sachs Group 183.94K sh · $85.67M · Q2 2026
- Charles Schwab Investment Management 170.36K sh · $79.34M · Q2 2026
- Arrowstreet Capital 166.15K sh · $77.38M · Q2 2026
- Norges Bank Investment Management 163.40K sh · $76.10M · Q2 2026
- Invesco Ltd 150.37K sh · $70.03M · Q2 2026